NASAL INFLUENZA VACCINE COMPOSITION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190091324A1
SERIAL NO

16200233

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an influenza vaccine composition for spray-administration to nasal mucosa, which comprises an inactivated whole influenza virion and a gel base material comprising carboxy vinyl polymer, which is characterized by not comprising an adjuvant.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASESNot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AINAI, Akira Tokyo, JP 3 4
HASEGAWA, Hideki Tokyo, JP 86 670
KAMISHITA, Taizou Osaka, JP 18 47
MIYAZAKI, Takashi Osaka, JP 144 1645
SUZUKI, Tadaki Tokyo, JP 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation